IRIS
MADEDDU, Denise
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.851
AS - Asia 2.699
EU - Europa 2.245
SA - Sud America 334
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 113
OC - Oceania 6
Totale 9.386
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.734
SG - Singapore 853
CN - Cina 808
IT - Italia 558
VN - Vietnam 427
SE - Svezia 374
IE - Irlanda 354
BR - Brasile 253
DE - Germania 221
FI - Finlandia 215
HK - Hong Kong 192
FR - Francia 125
BD - Bangladesh 105
TR - Turchia 79
ZA - Sudafrica 78
GB - Regno Unito 70
NL - Olanda 66
CA - Canada 65
IN - India 65
AT - Austria 56
UA - Ucraina 41
BE - Belgio 40
MX - Messico 30
CZ - Repubblica Ceca 28
IQ - Iraq 26
AR - Argentina 25
JP - Giappone 23
RU - Federazione Russa 22
PL - Polonia 21
EC - Ecuador 18
PH - Filippine 17
PK - Pakistan 15
ID - Indonesia 14
CO - Colombia 13
LT - Lituania 13
VE - Venezuela 12
CI - Costa d'Avorio 10
TH - Thailandia 10
MA - Marocco 9
ES - Italia 8
JO - Giordania 8
RO - Romania 8
UZ - Uzbekistan 8
JM - Giamaica 7
KR - Corea 7
AU - Australia 6
AZ - Azerbaigian 5
CH - Svizzera 5
CR - Costa Rica 5
OM - Oman 5
TN - Tunisia 5
TW - Taiwan 5
AL - Albania 4
KE - Kenya 4
NP - Nepal 4
UY - Uruguay 4
MY - Malesia 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
PE - Perù 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
Totale 9.250
Salva come PNG Salva come JPEG
Città #
Ashburn 488
Singapore 487
Chandler 395
Dublin 354
San Jose 329
Santa Clara 230
Dallas 212
Ann Arbor 186
Parma 185
Hong Kong 180
Beijing 165
Ho Chi Minh City 126
Boardman 120
Council Bluffs 115
Dearborn 113
New York 109
Hanoi 86
Shanghai 82
Los Angeles 80
Munich 76
Nanjing 76
Johannesburg 75
Izmir 58
Padova 57
Lauterbourg 55
Princeton 54
Bremen 49
Vienna 49
Wilmington 45
Jacksonville 44
Helsinki 43
Brussels 40
Buffalo 38
Nanchang 31
Jinan 28
São Paulo 28
Milan 27
Haiphong 25
Hebei 24
Columbus 21
Seattle 21
Toronto 21
Brooklyn 19
Phoenix 19
London 18
San Mateo 18
Frankfurt am Main 17
Hefei 17
Pune 17
Shenyang 17
Tokyo 17
Des Moines 16
Guangzhou 16
Jiaxing 16
Kunming 16
Rio Saliceto 16
Rome 16
Turku 16
Warsaw 16
Da Nang 15
Denver 15
Changsha 14
Houston 14
Montreal 14
Atlanta 13
Fremont 13
Norwalk 13
Brno 12
Moscow 12
Zhengzhou 12
Baghdad 11
Hải Dương 11
Modena 11
Stockholm 11
The Dalles 11
Tianjin 11
Abidjan 10
Boston 10
Nuremberg 10
Redmond 10
Tulsa 10
Chennai 9
Hangzhou 9
Mexico City 9
Woodbridge 9
Bologna 8
Chicago 8
Guayaquil 8
Olomouc 8
Rio de Janeiro 8
Amman 7
Can Tho 7
Charlotte 7
Falkenstein 7
Jakarta 7
Curitiba 6
Falls Church 6
Haikou 6
Kingston 6
Kocaeli 6
Totale 5.718
Salva come PNG Salva come JPEG
Nome #
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 297
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 228
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 223
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 222
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 218
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 209
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 206
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 203
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 201
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 200
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 197
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 196
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 192
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 192
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 189
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 188
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 182
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 181
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 179
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 178
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 176
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 175
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 171
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 169
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 168
Isolation and characterization of human lung lymphatic endothelial cells 168
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 167
Assessment of Cardiac Patches Suitability for Tissue Engineering 167
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 164
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 163
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 162
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 162
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 161
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 158
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 153
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 153
Resident cardiac stem cells. 151
Stem cells and myocardial regeneration 146
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 145
Development of biomimetic alginate/gelatin/elastin sponges with recognition properties toward bioactive peptides for cardiac tissue engineering 143
Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application 141
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 139
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 138
SURGICAL SAMPLING IS AN EMERGING ISSUE IN THE ASSESSMENT OF THE IMMUNE CONTEXTURE IN NON SMALL CELL LUNG CANCER (NSCLC) 132
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 130
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 126
IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium 123
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 119
Low vagally-mediated heart rate variability and increased susceptibility to ventricular arrhythmias in rats bred for high anxiety. 119
Correction: A versatile bioreactor for dynamic suspension cell culture. Application to the culture of cancer cell spheroids 116
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 115
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 113
Influence of injectable microparticle size on cardiac progenitor cell response 113
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS 107
Reinforced alginate/gelatin sponges functionalized by avidin/biotin-binding strategy: a novel cardiac patch 95
In vitro suspension bioreactor-based platform for culturing tumor cell clusters 89
Thermoreversible injectable polyurethane hydrogels: future challenges for biomedical applications 75
Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin model 74
Structural and functional characterization of vascular phenotype in lung cancer 19
Totale 9.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022236 0 0 0 14 4 10 39 21 12 21 11 104
2022/20231.524 160 186 102 121 160 156 37 81 428 10 69 14
2023/2024566 22 41 8 16 50 152 51 24 17 46 66 73
2024/20251.418 29 71 102 114 164 125 82 71 134 121 139 266
2025/20263.339 334 256 366 295 447 176 342 113 451 282 136 141
2026/2027522 64 180 152 126 0 0 0 0 0 0 0 0
Totale 9.386